From Mark Kelly <[email protected]>
Subject Ban Corporate PACs
Date February 14, 2024 10:02 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
[1]Mark Kelly for Senate

Friends —

When Gabby and I first kicked off this campaign, we wanted to do things a little differently.

To me, public service is about serving people. And I don't think you can do that very effectively if some big corporation has you in its pocket.

So, one of the first things we decided was that I was never — ever — going to take donations from corporate PACs. Not a dime.

This was a key piece of the platform I ran on in 2020, and again in 2022. And that’s why I reintroduced the Ban Corporate PACs Act with Jon Ossoff last month, before the anniversary of the Citizens United decision that opened the floodgates for corporate money in our elections.

Last year, pharmaceutical companies fought tooth and nail to block legislation that would reduce the cost of prescription medication for seniors. It’s an all too familiar story, and one that doesn’t often have a happy ending.

But this time, the pharmaceutical companies failed. Millions of people will benefit as a result.

And that’s why I’m writing. Things like this can make a big difference in Washington, so I’m asking you to endorse my standard of government. That means all members of Congress should:

1. Release their official schedule.

2. Place their assets in qualified blind trusts.

3. And refuse any donations from corporate PACs.

Please, add your name. This might sound like a small act. But with thousands signing on, it’s a message to my colleagues on the fence that our supporters will have our back if we do the right thing.

ADD YOUR NAME: [link removed]

I’m the only one in the Senate who does this today, but with any luck, we’ll pull a few more people to our side with your support.

Thanks for listening,

Mark Kelly
 


You can unsubscribe from this mailing list at any time:
[link removed]
Screenshot of the email generated on import

Message Analysis